ABSTRACTS SELECTED AS E-POSTERS
IN ALPHABETIC ORDER ACCORDING TO THE NAME OF THE FIRST
AUTHOR
BIOLOGY POSTERS
Poster 1: DNMT3A MUTATIONS PROMOTE MYELOID TRANSFORMATION IN
KMT2A-PTD-POSITIVE LEUKEMIA
Rabindranath Bera1, Ming-Chun Chiu1, Ying-Jung Huang1, Gang Huang2 and
Lee-Yung Shih1,3
Poster 2: PHOSPHOLIPASE C BETA1 (PI-PLCBETA1)/CYCLIN D3/PROTEIN KINASE
C (PKC) ALPHA SIGNALING MODULATION DURING IRON-INDUCED
OXIDATIVE STRESS IN MYELODYSPLASTIC SYNDROMES (MDS)
Alessia De Stefano1, Sara Mongiorgi1, Alessandra Cappellini1, Sarah Parisi2,
Miriam Fogli2, Antonietta Fazio1, Stefano Ratti1, Maria Vittoria Marvi1, Lucia
Manzoli1, Lucio Cocco1, Matilde Y. Follo1 and Carlo Finelli2
Poster 3: LEUKEMOGENESIS IN GATA2 HAPLOINSUFFICIENT MICE IS A
SECONDARY EVENT AFTER BMF
Juncal Fernandez Orth1, Julia Miriam Weiss1, Christian Molnar2, Irene
Gonzalez-Mendez3, Marcin Wlodarski4, Brigitte Strahm4, Doris Steinemann5,
Leticia Quintanilla-Martinez3, Charlotte Niemeyer4 and Miriam Erlacher1
Poster 4: CYTOGENETIC MARKERS WITH ROLE IN DISEASE EVOLUTION STUDIED
IN A GROUP OF 50 PATIENTS WITH MYELODYSPLASTIC SYNDROME
Nicorescu Iuliana,
Poster 5: PROGNOSTIC VALUE OF MONOCYTE SUBSET DISTRIBUTION IN
CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
Matthieu Jestin1, Sihem Tarfi1,2, Matthieu Duchmann3,4, Bouchra Badaoui1,
Nicolas Freynet1, Ivan Sloma1,2, Nathalie Droin5, Margot Morabito5, Sébastien
Maury6, Pierre Fenaux7, Eric Solary5,8,9, Dorothée Selimoglu-Buet5 and Orianne
Wagner-Ballon1,2
Poster 6: MODULATION OF THE IL-6/STAT3 SIGNALING AXIS IN CD4+ T CELLS
REPRESENTS A IMMUNE-MEDIATED MECHANISM OF ACTION OF
AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES
Eleftheria Lamprianidou1, Chrysoula Kordella1, Anastasiya Kazachenka2,
Emmanouela Zoulia1, Elsa Bernard3, Anastasia Filia4, Stamatia Laidou5,
Theodoros Vassilakopoulos6, Sotirios G. Papageorgiou7, Vassiliki Pappa8,
Athanasios G. Galanopoulos9, Nora Viniou10, Evangelia Nakou1, Anastasia
Hadzidimitriou5, George Kassiotis2,11, Elli Papaemmanuil3, Ioannis Mitroulis1
and Ioannis Kotsianidis1
SCIENTIFIC PROGRAMME
SESSION I
ETIOLOGY OF MDS
SESSION II
BIOLOGY OF MDS –
GENETIC ABNORMALITIES
SESSION III
BIOLOGY OF MDS:
STEM CELLS AND THE
MICROENVIRONMENT
SESSION IV
DIAGNOSTIC WORKUP
AND PROGNOSTIC
FACTORS IN MDS
SESSION V
SPECIFIC SUBTYPES
OF MDS, BASED ON
MORPHOLOGY AND
MOLECULAR BIOLOGY
SESSION VI
TREATMENT OF MDS
SESSION VII
CURRENT PROGRESS IN
THE TREATMENT OF MDS
SESSION VIII
FUTURE TREATMENTS
AND TREATMENT
STRATEGIES IN MDS
SESSION IX
LATE-BREAKING TALKS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
AS E-POSTERS
DISCLOSURES